79 reports

Targeted Therapies in Asthma: Update Bulletin ### [April 2018] This edition presents key opinion leader (KOL) views on recent developments in the Alzheimer’s Disease (AD) market.

  • Dementia
  • Mental Health
  • Pathology
  • Therapy

Leukotriens drive inflammation and are known to cause asthma.

  • Cancer
  • Dementia
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited
  • NEURODEGENERATIVE DISORDERS THERAPEUTICS MARKET, COMORBIDITIES ASSOCIATED WITH

CNS Drugs; ##(##): ##-## Götz J, et al. (2008).

  • Dementia
  • World
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • Alzheimer's Disease Drugs Sales Volume

High blood pressure and anxiety as well as other respiratory problems like asthma, bronchitis, and poor circulation.

  • Dementia
  • China
  • Trade
  • Janssen Biotech, Inc.
  • Xian-Janssen Pharmaceutical Ltd.
  • Alzheimer's Disease Drugs Sales Volume
  • Alzheimer's Disease Drugs Sales Volume

High blood pressure and anxiety as well as other respiratory problems like asthma, bronchitis, and poor circulation.

  • Dementia
  • China
  • Demand
  • Guizhou Yibai Pharmaceutical Co., Ltd.
  • Kunming Longjin Pharmaceutical Co Ltd
  • 12.1 BIBLIOGRAPHY

A FOOD AND DRUG ADMINISTRATION-APPROVED ASTHMA THERAPEUTIC AGENT IMPACTS AMYLOID Β CHEMISTRY; ##(##): 1966-1978.

  • Dementia
  • Allergan plc
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Novartis AG

Drivers and their Impact Impact on Key Customer Segments Driver Unmet Medical Needs Increase in Patient Population Low Low ## ## ## ## ## High High Hospitals ## ## ## ## ## Promising Drug Pipeline Special Provision for Rare Diseases Low Low ## ## ## ## ## High High ## ## ## ## ##

  • Dementia
  • Biogen Idec Inc.
  • Merck Serono S.A.
  • Novartis AG
  • Pfizer Inc.
  • 4.3.4 AZD3293 - ASTRAZENECA

In addition to mild-to-moderate AD, masitinib is being trialed for multiple sclerosis, asthma and various cancers.

  • Dementia
  • East Asia
  • World
  • Forecast
  • Biogen Idec Inc.
  • Alzheimer's Disease Market, Global, AZD3293 Market Forecast ($m), 2019-2021
  • 5.4.4 AB1010 - AB SCIENCE

Besides mild-to-moderate AD, masitinib is being trialed for multiple sclerosis, asthma and various cancers.

  • Dementia
  • World
  • Forecast
  • Market Size
  • Eisai Co., Ltd.
  • PRODUCT PROFILE - AB-1010

ALZHEIMER' S & DEMENTIA; ##(##): ##-##.

  • Dementia
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group

Each security is composed of one ordinary share and one warrant.

  • Antimalarials
  • Dementia
  • Healthcare
  • Therapy
  • AB Science SA

IT AFFECTS ## IN ##, ## TO ## IN ##, ## BIRTHS.

  • Clinical Trial
  • Dementia
  • Hospital
  • Nucleic Acid
  • GlobalData's company

It effects from ## in ## to ## in 2000 people worldwide.

  • Clinical Trial
  • Dementia
  • Prostate Cancer
  • United States
  • GlobalData's company
  • Amyotrophic Lateral Sclerosis
  • MASITINIB - DRUG PROFILE

It is also developing new approaches to the treatment of asthma.

  • Dementia
  • Therapy
  • United States
  • Product Initiative
  • AB Science SA
  • registered with U.S. National Institutes of Health.
  • MASITINIB - DRUG PROFILE

This patent, which expires in 2032 protects to the use of masitinib in the treatment of severe persistent corticosteroid-dependent asthma and severe persistent corticosteroid-resistant asthma.

  • Dementia
  • Neurological Disorder
  • United States
  • Product Initiative
  • AB Science SA
  • NEFLAMAPIMOD - DRUG PROFILE

It is also developing new approaches to the treatment of asthma.

  • Dementia
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Neurim offers treatments for other therapeutic areas that include Parkinson" s disease, and asthma or chronic obstructive pulmonary disease.

  • Dementia
  • Pain Relief
  • United States
  • Product Initiative
  • Flex Pharma, Inc.
  • PIPELINE BY LES LABORATOIRES SERVIER SAS, H1 2018
  • PIPELINE BY ONO PHARMACEUTICAL CO LTD, H1 2018

Its product portfolio includes pharmaceuticals for the treatment of diseases such as type II diabetes, overactive bladder, osteoporosis, Alzheimer' s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others.

  • Dementia
  • Mental Health
  • Therapy
  • World
  • Product Initiative

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Clinical Trial
  • Dementia
  • Pathology
  • Therapy
  • GlobalData's company
  • ADC THERAPEUTICS RAISES USD80 MILLION IN PRIVATE PLACEMENT OF SHARES
  • ADC THERAPEUTICS RAISES USD105 MILLION IN PRIVATE PLACEMENT OF SHARES

It is also developing new approaches to the treatment of asthma.

  • Dementia
  • Switzerland
  • United Kingdom
  • United States
  • ADC Therapeutics SA
  • MASITINIB - DRUG PROFILE

This patent, which expires in 2032 protects to the use of masitinib in the treatment of severe persistent corticosteroid-dependent asthma and severe persistent corticosteroidresistant asthma.

  • Dementia
  • Mental Health
  • United States
  • Product Initiative
  • AB Science SA
  • PIPELINE BY ACTINOGEN MEDICAL LTD, H1 2018

It is also developing new approaches to the treatment of asthma.

  • Dementia
  • United Kingdom
  • World
  • Product Initiative
  • Actinogen Limited
  • MILD COGNITIVE IMPAIRMENT - PIPELINE BY ENSOL BIOSCIENCES INC, H2 2017
  • Indication Name

One of these mechanisms, leukotriene signaling, is related to asthma.

  • Dementia
  • United States
  • Company
  • Product Initiative
  • Suven Life Sciences Ltd
  • DORMANT PRODUCTS, H2 2017 (CONTD..2), H2 2017

Patients will be randomized to receive one of two doses of BNC## (##mg or 2000mg) or one of two controls, placebo or ##. ##mg Lorazepam.

  • Dementia
  • Pharmaceutical
  • United States
  • Product Initiative
  • Bionomics
  • ALZHEIMER'S DISEASE - PIPELINE BY PHARMAXIS LTD
  • ALZHEIMER'S DISEASE - PIPELINE BY PHARNEXT SA

One of these mechanisms, leukotriene signaling, is related to asthma.

  • Dementia
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative

This Phase ## clinical trial in healthy volunteers for DNL## is continuing.

  • Dementia
  • Therapy
  • United States
  • Company
  • Denali Therapeutics Inc.
  • PIPELINE BY ASTRAZENECA PLC, H1 2018
  • PIPELINE BY H. LUNDBECK AS, H1 2018

It is also developing new approaches to the treatment of asthma.

  • Dementia
  • United States
  • Company Operations
  • Product Initiative
  • Eisai Co., Ltd.

This Phase ## clinical trial in healthy volunteers for DNL## is continuing.

  • Dementia
  • Therapy
  • United States
  • Company
  • Denali Therapeutics Inc.

Medicine; ##(##): DOI: ##. ##/ cshperspect. a##.

  • Dementia
  • Neurological Disorder
  • Psychotic Disorder
  • World
  • Deals & Alliance